PL EN


Preferences help
enabled [disable] Abstract
Number of results
2019 | 120 | 2 | 286-290
Article title

Endothelial progenitor cell dysfunction: is it best fitted for risk stratification in pulmonary disease?

Content
Title variants
Languages of publication
EN
Abstracts
EN
Endothelial progenitor cell (EPC) dysfunction is defined as weak function and lowered number of endothelial precursors with pro-angiogenic phenotypes that are imbedded in vascular integrity maintenance, angiogenesis, and vascular reparation. There is large body of evidence that deficiency of EPC number in peripheral blood is considered as a marker of endothelial dysfunction, which is established risk factor and player in pathogenesis of cardiovascular disease. Moreover, recent clinical studies have shown that circulating EPCs had demonstrated vascular protection in several vascular diseases including pulmonary hypertension. However, the role of EPCs in pathogenesis chronic obstructive pulmonary disease bronchial asthma, emphysema appeared to be uncertain. The short communication is dedicated the controversies in abilities of EPCs to have tissue protective and play a pivotal role in nature evolution of pulmonary disease.
Discipline
Year
Volume
120
Issue
2
Pages
286-290
Physical description
Contributors
  • Internal Medicine Department, State Medical University of Zaporozhye, 26, Mayakovsky av., Zaporozhye, Ukraine
  • Internal Medicine Department, Medical Academy of Postgraduate Education, Zaporozhye, Ukraine
References
  • [1] Patel J, Donovan P, Khosrotehrani K. Concise Review: Functional Definition of Endothelial Progenitor Cells: A Molecular Perspective. Stem Cells Transl Med. 2016; 5(10): 1302-1306
  • [2] Masuda H, Alev C, Akimaru H, et al. Methodological development of a clonogenic assay to determine endothelial progenitor cell potential. Circ Res. 2011; 109: 20–37
  • [3] Patel J, Seppanen E, Chong MS, et al. Prospective surface marker-based isolation and expansion of fetal endothelial colony-forming cells from human term placenta. Stem Cells Translational Medicine 2013; 2: 839–847
  • [4] He S, Nakada D, Morrison SJ. Mechanisms of stem cell self-renewal. Annu Rev Cell Dev Biol. 2009; 25: 377–406
  • [5] Berezin A. The endothelial progenitor cell dysfunction in hypertension: the diagnostic and predictive values. Vessel Plus. 2018; 2: 22. doi:10.20517/2574-1209.2018.23
  • [6] Keighron C, Lyons CJ, Creane M, O'Brien T, Liew A. Recent Advances in Endothelial Progenitor Cells Toward Their Use in Clinical Translation. Front Med (Lausanne). 2018; 5: 354. doi:10.3389/fmed.2018.00354
  • [7] Berezin A, Kremzer A, Berezina T, Martovitskaya Y, Gromenko E. Data regarding association between serum osteoprotegerin level, numerous of circulating endothelial-derived and mononuclear-derived progenitor cells in patients with metabolic syndrome. Data in Brief. 2016; 8: 717-722. doi:10.1016/j.dib.2016.06.015
  • [8] Berezin A. Up-to-date clinical approaches of biomarkers’ use in heart failure. Biomed Res Ther. 2017; 4(6): 1341-1370 doi:10.15419/bmrat.v4i06.178
  • [9] O'Neill CL, McLoughlin KJ, Chambers SEJ, Guduric-Fuchs J, Stitt AW, Medina RJ. The Vasoreparative Potential of Endothelial Colony Forming Cells: A Journey Through Pre-clinical Studies. Front Med (Lausanne) 2018; 5: 273. doi:10.3389/fmed.2018.00273
  • [10] Berezin A. Progenitor endothelial cell dysfunction in heart failure: clinical implication and therapeutic target? Translational Medicine 2016; 6(3): 176-177. doi:10.4172/2161-1025.1000176
  • [11] Guerra G, Perrotta F, Testa G. Circulating Endothelial Progenitor Cells Biology and Regenerative Medicine in Pulmonary Vascular Diseases. Curr Pharm Biotechnol. 2018; 19(9): 700-707. doi:10.2174/1389201019666181017161752
  • [12] Berezin A. Epigenetically Modified Endothelial Progenitor Cells in Heart Failure. J Clin Epigenet. 2016; 2(2): 21-23
  • [13] Rafii S, Butler JM, Ding BS. Angiocrine functions of organ-specific endothelial cells. Nature 2016; 529: 316–325
  • [14] Coppolino I, Ruggeri P, Nucera F, Cannavò MF, Adcock I, Girbino G, et al. Role of Stem Cells in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Pulmonary Emphysema. COPD 2018; 15(5): 536-556. doi:10.1080/15412555.2018.1536116
  • [15] Salter B, Sehmi R. The role of bone marrow-derived endothelial progenitor cells and angiogenic responses in chronic obstructive pulmonary disease. J Thorac Dis. 2017; 9(7): 2168-2177. doi: 10.21037/jtd.2017.07.56
  • [16] Doyle MF, Tracy RP, Parikh MA, Hoffman EA, Shimbo D, Austin JH, et al. Endothelial progenitor cells in chronic obstructive pulmonary disease and emphysema. PLoS One 2017; 12(3): e0173446. doi:10.1371/journal.pone.0173446
  • [17] Palange P, Testa U, Huertas A, Calabro L, Antonucci R, Petrucci E et al. Circulating haemopoietic and endothelial progenitor cells are decreased in COPD. Eur Respir J. 2006; 27: 529–541
  • [18] García-Lucio J, Peinado VI, de Jover L, Del Pozo R, Blanco I, Bonjoch C, et al. Imbalance between endothelial damage and repair capacity in chronic obstructive pulmonary disease. PLoS One 2018; 13(4): e0195724. doi:10.1371/journal.pone.0195724
  • [19] Liu X, Liu Y, Huang X, Lin G, Xie C. Endothelial progenitor cell dysfunction in acute exacerbation of chronic obstructive pulmonary disease. Mol Med Rep. 2017; 16(4): 5294-5302. doi:10.3892/mmr.2017.7260
  • [20] Malerba M, Nardin M, Radaeli A, Montuschi P, Carpagnano GE, Clini E. The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients. Expert Rev Hematol. 2017; 10(9): 821-832. doi:10.1080/17474086.2017.1353416..
  • [21] Berezin A. The Role of Progenitor Endothelial Cell Dysfunction in Arterial Hypertension. Biological Markers and Guided Therapy 2018; 5(1): 31-36 doi:10.12988/bmgt.2018.845
  • [22] Shi Z, Chen Y, Cao J, Zeng H, Yang Y, Chen P, et al. Intratracheal transplantation of endothelial progenitor cells attenuates smoking-induced COPD in mice. Int J Chron Obstruct Pulmon Dis. 2017; 12: 947-960. doi:10.2147/COPD.S110781
  • [23] Salter BM, Manzoor F, Beaudin S, Kjarsgaard M, Nair P, Gauvreau GM, et al. Dysregulation of Vascular Endothelial Progenitor Cells Lung-Homing in Subjects with COPD. Can Respir J. 2016; 2016: 1472823. doi:10.1155/2016/1472823
Document Type
short_communication
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.psjd-8d7c9465-470e-448a-87e0-371a7b20bd50
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.